Mir-148A-3p Represses Proliferation and EMT by Establishing Regulatory Circuits Between ERBB3/AKT2/c-myc and DNMT1 in Bladder Cancer

Xiao Wang,Zhen Liang,Xin Xu,Jiangfeng Li,Yi Zhu,Shuai Meng,Shiqi Li,Song Wang,Bo Xie,Alin Ji,Ben Liu,Xiangyi Zheng,Liping Xie
DOI: https://doi.org/10.1038/cddis.2016.373
2016-01-01
Cell Death and Disease
Abstract:miR-148a-3p downregulation has emerged as a critical factor in cancer progression yet, the underlying mechanisms of miR-148a-3p expression pattern and its function in bladder cancer remains to be elucidated. Here, we illustrate that miR-148a-3p is frequently downregulated in bladder cancer and that its expression may be regulated by DNA methylation. DNA methyltransferase 1 (DNMT1) and miR-148a-3p function in a positive feedback loop in bladder cancer. miR-148a-3p overexpression functions as a tumor suppressor in bladder cancer cells. miR-148a-3p inhibits bladder cancer cell proliferation and epithelial-mesenchymal transition (EMT) by regulating ERBB3/AKT2/c-myc and ERBB3/AKT2/Snail signaling. ERBB3, DNMT1 and AKT2 are downstream miR-148a-3p target genes. Furthermore, the miR-148a-3p/ERBB3/AKT2/c-myc signaling axis establishes a positive feedback loop in the regulation of bladder cancer. Taken together, our study demonstrates novel regulatory circuits involving miR-148a-3p/ERBB3/AKT2/c-myc and DNMT1 that controls bladder cancer progression, which may be useful in the development of more effective therapies against bladder cancer.
What problem does this paper attempt to address?